JAZZ Form 144: 3,731 shares from restricted stock vesting to be sold

Rhea-AI Filing Summary

Jazz Pharmaceuticals (JAZZ) filed a Rule 144 notice reporting a proposed sale of 3,731 common shares with an aggregate market value of $417,872. The sale is scheduled on NASDAQ for 08/08/2025 and lists E*TRADE Financial Corporation as broker.

The filing shows these shares were acquired on 08/07/2025 through restricted stock vesting from the issuer and were paid as compensation. The filing also reports 60,658,809 shares outstanding and notes "Nothing to Report" for securities sold in the past three months.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small insider sale from vested restricted stock; unlikely to be market-moving.

The filing documents a proposed sale of 3,731 common shares valued at $417,872 to be executed on NASDAQ. The shares were acquired one day earlier through restricted stock vesting and classified as compensation. As a securities analyst, this reads as a standard insider reporting requirement under Rule 144 rather than an indication of new corporate developments; the filing contains no disclosures of material nonpublic information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing internal compensation vesting and a required resale notice; governance risk appears limited.

The notice confirms the seller represents there is no undisclosed material adverse information and references trading-plan language. The transaction arises from restricted stock vesting and the signature attestation is standard for Form 144 filings. From a governance perspective, the filing documents routine insider activity and the required compliance statements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	ETRADE FINANCIAL CORPORATION ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	3731	417872.00	60658809	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/07/2025	RESTRICTED STOCK VESTING	ISSUER			3731	08/07/2025	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Jazz Pharmaceuticals (JAZZ) report?

The filing reports a proposed sale of 3,731 common shares with an aggregate market value of $417,872 to be sold on 08/08/2025 on NASDAQ.

How were the securities being sold acquired?

The securities were acquired on 08/07/2025 through restricted stock vesting from the issuer and the payment is listed as compensation.

Who is the broker listed on the Form 144?

The broker is listed as E*TRADE Financial Corporation with an address at 3 Edison Drive, Alpharetta, GA 30005.

How many shares outstanding does the filing list for the issuer?

The filing lists 60,658,809 shares outstanding.

Were any securities sold by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.